Schizophrenia.com

Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia

everhopeful November 16, 2023, 9:15pm 1

4 Likes

Topic		Replies	Views	Activity
Karuna Therapeutics Announces The Lancet Publication of Data from Phase 3 EMERGENT-2 Trial Evaluating KarXT in Schizophrenia News	1	270	December 15, 2023
Karuna Therapeutics Announces Results from Phase 1b Trial News	3	266	June 23, 2021
KarXT new AP Karuna Therapeutics Announces New England Journal of Medicine Publication of DX'd - Other	2	180	February 10, 2022
Karuna: NDA Filing Q3 Of 2023 And Expanded Potential With KarXT (NASDAQ:KRTX) News	0	367	August 24, 2023
Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia News	22	839	November 24, 2019